Bio-Techne TECH Business Segments
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Diagnostics And Spatial Biology | $335.93M-3.3% | $339.57M-1.7% | $342.53M+1.7% | $346.26M+6.1% | $347.24M+12.4% | |
| Protein Sciences | $869.9M+1.4% | $871.43M+3.2% | $867.9M+4.5% | $870.24M+4.7% | $857.76M+2.1% | |
| Operating Income by Business | ||||||
| Diagnostics And Spatial Biology | $33.01M+20.9% | $31.12M+15.3% | $25.93M-8.4% | $21.32M-13.1% | $27.3M+14.0% | |
| Protein Sciences | $361.12M-0.7% | $365.03M+3.0% | $367.52M+5.9% | $370.35M+4.4% | $363.56M+0.3% | |
| Selling General And Administrative Expense by Business | ||||||
| Diagnostics And Spatial Biology | $117.17M-12.4% | $122.97M-6.9% | $130.44M+1.2% | $136.1M+7.1% | $133.78M+10.7% | |
| Protein Sciences | $235.31M+4.7% | $233.2M+4.5% | $231.69M+5.3% | $229.06M+5.4% | $224.73M+5.0% | |
| Cost of Goods Sold by Business | ||||||
| Diagnostics And Spatial Biology | $148.39M+4.4% | $146.93M+5.9% | $146.05M+6.7% | $147.95M+9.6% | $142.16M+9.7% | |
| Protein Sciences | $215.95M+3.8% | $215.35M+4.8% | $210.25M+3.1% | $212.23M+5.1% | $208.11M+2.1% | |
| Restructuring Charges by Business | ||||||
| Corporate | $2.32M— | $1.92M— | $1.71M— | $1.1M— | —— | |
| Protein Sciences | $9.01M-28.9% | $7.02M-44.3% | $6.91M-29.7% | $13.4M+6,599% | $12.66M+1,110% | |
| Research And Development Expense Excluding Acquired In Process Cost by Business | ||||||
| Diagnostics And Spatial Biology | $37.37M-6.9% | $38.56M-3.3% | $40.12M+1.4% | $40.89M+2.9% | $40.14M+4.6% | |
| Protein Sciences | $57.53M-1.5% | $57.85M0.0% | $58.44M+2.4% | $58.61M+3.0% | $58.4M+2.0% | |
| Goodwill by Business | ||||||
| Diagnostics And Spatial Biology | $2.22B+0.9% | $2.21B— | $2.2B— | $2.2B— | $2.2B— | |
| Protein Sciences | $1.7B+0.6% | $1.7B+0.3% | $1.69B-0.4% | $1.69B-0.2% | $1.69B-0.6% | |
| Goodwill Foreign Currency Translation Gain Loss by Business | ||||||
| Diagnostics And Spatial Biology | $10.61M+629% | $14.36M+388% | $2.51M-58.4% | $9.43M+923% | -$2M— | |
| Revenue by Product | ||||||
| Consumables | $977.32M+1.3% | $977.77M+2.5% | $973.04M+4.1% | $972.29M+4.8% | $965.12M+4.3% | |
| Instruments | $108M-2.1% | $106.44M-3.8% | $107.71M-1.7% | $112.09M+3.5% | $110.28M+1.1% | |
| Royalty | $24.63M+6.0% | $24.7M+7.9% | $24.29M+8.8% | $23.69M+1.5% | $23.24M0.0% | |
| Service | $100.86M-8.4% | $106.66M-1.6% | $111.7M+6.2% | $111.57M+12.4% | $110.13M+14.4% | |
| Revenue by Geography | ||||||
| APAC Excluding Greater China | $82.6M+6.4% | $82.02M+9.9% | $78.29M+4.8% | $77.26M+4.5% | $77.64M+7.5% | |
| CN | $104.06M+6.7% | $102.53M+4.0% | $100.93M+2.7% | $100.46M+1.0% | $97.48M-3.8% | |
| EMEA Excluding UK | $284.28M+9.5% | $277.33M+9.4% | $272.37M+10.9% | $266.31M+10.3% | $259.52M+9.1% | |
| GB | $56.61M+9.3% | $54.57M+0.9% | $54.09M+5.0% | $54.83M+9.6% | $51.8M+0.9% | |
| Rest Of World | $37.61M-0.9% | $39.02M-0.9% | $37.6M-0.4% | $37.55M+2.9% | $37.95M+3.9% | |
| US | $645.66M-5.7% | $660.11M-2.3% | $673.46M+1.5% | $683.23M+3.9% | $684.38M+4.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bio-Techne break its business down?
- Bio-Techne (TECH) reports revenue by business across 2 parts — Diagnostics And Spatial Biology and Protein Sciences. Each is extracted from the segment footnotes and tracked over time.
- Where does Bio-Techne's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bio-Techne's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
